Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Traphaco is a leading pharmaceutical company in Vietnam, specializing in the research, development, and commercialization of both traditional herbal medicines and modern western pharmaceuticals. Founded in 1972, the company has established itself as a dominant player in the Vietnamese market, particularly known for its flagship liver tonic 'Boganic' and brain circulation enhancer 'Hoat Huyet Duong Nao'. Traphaco operates multiple GMP-WHO certified manufacturing facilities and maintains a robust distribution network across Southeast Asia. The company is publicly traded on the Ho Chi Minh Stock Exchange and is recognized for its commitment to sustainable development and the modernization of traditional medicine through advanced technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Telecommunications Regulatory Authority.